Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - LONG-TERM DEBT
Long-term Debt KROS - Keros Therapeutics, Inc.
13.4 M
LAST VALUE
439.34%
2 YEAR CAGR
84.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR